Safety, Tolerability, and Pharmacokinetics of SAB-176 in Healthy Participants

NCT04471038 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
27
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

SAb Biotherapeutics, Inc.